Moreover, studies have shown that the degree of tumor dedifferentiation correlates with the magnitude of activation of the MAPK pathway, and that BRAF V600E mutations lead to greater MAPK activation than RAS or RTK alterations (11, 110, 111). Here, BRAF is linked to neoplasm.